Evidence map›Paper›PMID 18324565›Full record

Trial reportNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2008

Older versus younger treatment-seeking smokers: differences in smoking behavior, drug and alcohol use, and psychosocial and physical functioning.

Sharon M Hall, Gary L Humfleet, Julie A Gorecki, Ricardo F Muñoz, Victor I Reus, Judith J Prochaska

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Organic cation transporter variation and response to smoking cessation therapies.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2014
    Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Comparative Effectiveness of Varenicline and Nicotine Replacement Therapy for Smoking Cessation in Older and Younger Smokers: A Prospective Cohort in Taiwan.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2019
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sharon M HallUniversity of California, San Francisco, San Francisco, CA 94143-0984, USA. shall@lppi.ucsf.edu
Gary L Humfleet
Julie A Gorecki
Ricardo F Muñoz
Victor I Reus
Judith J Prochaska
University of California, San Francisco · US

Funding

TREATMENTS FOR COMPLEX PATIENTS IN NEW SETTINGSP50DA009253 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HALL, SHARON M. · 1994 to 2014
$28.2M
Maintaining Nonsmoking: Treatment of Older SmokersR01DA002538 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HUMFLEET, GARY L · 1985 to 2013
$5.4M
Evaluation of Tobacco Treatment Strategies for Inpatient PsychiatryR01MH083684 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PROCHASKA, JUDITH J. · 2009 to 2013
$2.6M
Maintaining Abstinence in Chronic Cigarette SmokersR01DA015732 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HALL, SHARON M. · 2002 to 2006
$2.5M
Treatment of Complex Patients: Emphasis on NicotineK05DA016752 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HALL, SHARON M. · 2003 to 2012
$1.1M
Treating Tobacco Dependence in Inpatient PsychiatryK23DA018691 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PROCHASKA, JUDITH J. · 2005 to 2009
$769k
NIDA NIH HHS K05 DA016752NIDA NIH HHS K23 DA018691NIDA NIH HHS P50 DA009253NIDA NIH HHS P50 DA09253NIDA NIH HHS R01 DA002538NIDA NIH HHS R01 DA015732NIDA NIH HHS R01 DA02538NIMH NIH HHS R01 MH083684
6 · The paper itself

Abstract

Quitting smoking benefits older individuals, yet few recent studies have described older smokers. The goal of this paper was to test a series of hypotheses about differences between smokers aged 50 years or older (50+) and those younger than age 50 (<50) presenting to the same treatment facility during 2002-2004 for participation in two randomized clinical trials: one exclusively for smokers aged 50+, and a second open to smokers aged 18 or older. As predicted, smokers aged 50+ were more tobacco dependent, had better psychological functioning, and had poorer physical functioning than those aged <50. Contrary to predictions, we found no differences in motivation to quit cigarette smoking or in alcohol use. Women aged 50+ were less likely to report marijuana use than women aged <50, and less likely than men to receive a positive diagnosis for alcohol abuse. Despite higher scores on measures of tobacco dependence, older smokers were less likely to be diagnosed as tobacco dependent or as having tobacco withdrawal using DSM-IV criteria. Rates of DSM-IV alcohol abuse and dependence were high in both age groups but were higher for smokers aged <50. We found no striking differences between studies in reasons for exclusion, but in both the proportion of individuals excluded due to current antidepressant use was high. Implications for the assessment and treatment of older adults are discussed.

Indexed as

Health BehaviorSocial EnvironmentAdultAge DistributionAlcohol DrinkingAntidepressive AgentsBehavior TherapyFemaleHumansMaleMiddle AgedNicotineSex DistributionSmokingSmoking CessationSmoking PreventionAntidepressive AgentsNicotine

Identifiers

PMID18324565
PMCPMC3247917
OpenAlexW2052361703

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.